CA1193606A - Substituted phenylpyrazole derivatives, process for their preparation, medicaments based therein, and their use - Google Patents
Substituted phenylpyrazole derivatives, process for their preparation, medicaments based therein, and their useInfo
- Publication number
- CA1193606A CA1193606A CA000421424A CA421424A CA1193606A CA 1193606 A CA1193606 A CA 1193606A CA 000421424 A CA000421424 A CA 000421424A CA 421424 A CA421424 A CA 421424A CA 1193606 A CA1193606 A CA 1193606A
- Authority
- CA
- Canada
- Prior art keywords
- amino
- formula
- phenyl
- ethyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims abstract description 10
- 150000008048 phenylpyrazoles Chemical class 0.000 title claims abstract description 5
- 238000002360 preparation method Methods 0.000 title claims abstract description 4
- 239000003814 drug Substances 0.000 title description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 29
- 239000002253 acid Substances 0.000 claims abstract description 23
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- 150000007513 acids Chemical class 0.000 claims abstract description 5
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 31
- -1 nitro, amino Chemical group 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- NPLSMQWSKZXZPD-UHFFFAOYSA-N 2,3-dihydropyrrol-1-amine Chemical compound NN1CCC=C1 NPLSMQWSKZXZPD-UHFFFAOYSA-N 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 208000007107 Stomach Ulcer Diseases 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000028327 secretion Effects 0.000 abstract description 3
- 238000002560 therapeutic procedure Methods 0.000 abstract description 3
- 210000004211 gastric acid Anatomy 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 11
- 150000002825 nitriles Chemical class 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical class NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 238000007363 ring formation reaction Methods 0.000 description 4
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 229940093499 ethyl acetate Drugs 0.000 description 3
- 235000019439 ethyl acetate Nutrition 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- FLAYZKKEOIAALB-UHFFFAOYSA-N 2-bromo-1-(4-chlorophenyl)ethanone Chemical compound ClC1=CC=C(C(=O)CBr)C=C1 FLAYZKKEOIAALB-UHFFFAOYSA-N 0.000 description 2
- 125000006282 2-chlorobenzyl group Chemical group [H]C1=C([H])C(Cl)=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- GASVEOUXCUOHGU-UHFFFAOYSA-N (4-amino-1-benzyl-2,3-dihydropyrrol-5-yl)-(4-chlorophenyl)methanone Chemical compound C1CC(N)=C(C(=O)C=2C=CC(Cl)=CC=2)N1CC1=CC=CC=C1 GASVEOUXCUOHGU-UHFFFAOYSA-N 0.000 description 1
- ZQXCQTAELHSNAT-UHFFFAOYSA-N 1-chloro-3-nitro-5-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(C(F)(F)F)=C1 ZQXCQTAELHSNAT-UHFFFAOYSA-N 0.000 description 1
- NUAIPKMBWNVQIM-UHFFFAOYSA-N 2-bromo-1-(3,4-dimethoxyphenyl)ethanone Chemical compound COC1=CC=C(C(=O)CBr)C=C1OC NUAIPKMBWNVQIM-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OEDUIFSDODUDRK-UHFFFAOYSA-N 5-phenyl-1h-pyrazole Chemical compound N1N=CC=C1C1=CC=CC=C1 OEDUIFSDODUDRK-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 101000618133 Homo sapiens Sperm-associated antigen 5 Proteins 0.000 description 1
- 241000243251 Hydra Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- 241001072332 Monia Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- PQUGCKBLVKJMNT-UHFFFAOYSA-N SC560 Chemical compound C1=CC(OC)=CC=C1N1C(C=2C=CC(Cl)=CC=2)=CC(C(F)(F)F)=N1 PQUGCKBLVKJMNT-UHFFFAOYSA-N 0.000 description 1
- 102100021915 Sperm-associated antigen 5 Human genes 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- MIYFPUCZNIEEFR-UHFFFAOYSA-N [4-amino-1-(3-phenylpropyl)-2,3-dihydropyrrol-5-yl]-phenylmethanone Chemical compound C1CC(N)=C(C(=O)C=2C=CC=CC=2)N1CCCC1=CC=CC=C1 MIYFPUCZNIEEFR-UHFFFAOYSA-N 0.000 description 1
- YBJOTENYCNZSBI-UHFFFAOYSA-N [4-amino-1-[(2-chlorophenyl)methyl]-2,3-dihydropyrrol-5-yl]-phenylmethanone Chemical compound C1CC(N)=C(C(=O)C=2C=CC=CC=2)N1CC1=CC=CC=C1Cl YBJOTENYCNZSBI-UHFFFAOYSA-N 0.000 description 1
- JBSGZEANXPQTMN-UHFFFAOYSA-N [5-amino-2-[(3-methoxyphenyl)methyl]pyrazolidin-1-yl]-phenylmethanone Chemical compound COC1=CC=CC(CN2N(C(N)CC2)C(=O)C=2C=CC=CC=2)=C1 JBSGZEANXPQTMN-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 101150014174 calm gene Proteins 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- OYFJQPXVCSSHAI-QFPUQLAESA-N enalapril maleate Chemical compound OC(=O)\C=C/C(O)=O.C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 OYFJQPXVCSSHAI-QFPUQLAESA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- KHJPMUNVSXZNAR-UHFFFAOYSA-N n-[(3-methoxyphenyl)methyl]-2-(3-phenyl-1h-pyrazol-5-yl)ethanamine Chemical compound COC1=CC=CC(CNCCC=2NN=C(C=2)C=2C=CC=CC=2)=C1 KHJPMUNVSXZNAR-UHFFFAOYSA-N 0.000 description 1
- ARAXEZCHGRTIJK-UHFFFAOYSA-N n-benzyl-2-(3-phenyl-1h-pyrazol-5-yl)ethanamine Chemical compound C=1C=CC=CC=1CNCCC(NN=1)=CC=1C1=CC=CC=C1 ARAXEZCHGRTIJK-UHFFFAOYSA-N 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- LMAZKPOSWVOFGY-FBAUPLQOSA-N orine Natural products CO[C@H]1C[C@H](O[C@H]2CC[C@]3(C)[C@H]4C[C@@H](OC(=O)C=Cc5ccccc5)[C@]6(C)[C@@](O)(CC[C@]6(O)[C@]4(O)CC=C3C2)[C@H](C)OC(=O)C=Cc7ccccc7)O[C@H](C)[C@H]1O LMAZKPOSWVOFGY-FBAUPLQOSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 238000005956 quaternization reaction Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical compound NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 150000003509 tertiary alcohols Chemical class 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/022—Boron compounds without C-boron linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
Abstract
Abstract of the disclosure:
Substituted phenylpyrazole derivatives of the formula
Substituted phenylpyrazole derivatives of the formula
Description
~9;~
- 2 - ilOE 82/F 025 The invention provides substituted phenylpyrazole deri~atives of the formula I
~1 ~ . 11 (I) ~"~,~ /Y~R3 and their salts with physiologically acceptable acids, which due to their pharmacoloyical properties cal1 be used as medicaments.
In the formula I, R1 and R2, which may be identical or different, are hydrogen, halogen, alkyl or alkoxy having from 1 to 4 carbon atoms, nitro or amino, R3 is hydrogen, a saturated or unsaturated, linear or branched a].kyl radical having from 1 to 8 carbon atoms, or a cycloalkyl radical having from 5 to 8 ca~.bon atoms;
the alkyl or cycloalkyl radical in turn may be substituted by a phenyl radical or a phenyl radical which may be mono~
or disubstituted by halogen, nitro, ami.no or alkyl or alkoxy having from 1 to 4 carbon atoms.
Preferred are those compounds of the formula I, in which R1 and R2 are identical or different and represent hydrogen, chlorine, fluorine, methyl or methoxy, and R3 is hydrogen or an alkyl chain having from 1 to 4 carbon atoms, which in turn may be substituted by phenyl optionally mono- or disubstituted by ch]orine, fluori.ne, methyl, methoxy, nitro or amino.
30- Especially preferred are those compounds of the formula I, in which R1 is hydrogen and R2 is chlorine, fluorine, me-thyl or me-thoxy,or R1 and R2 each are metl1oxy, and R3 is hydrogen or an al~yl chaill having from 1 to 4 carbon atoms, which in turn may be suhstituted by phenyl optionally mono- or dlsubstituted by chlol^irle, fluorine, methyl or methoxy .
.,, , , ~
~93~06
~1 ~ . 11 (I) ~"~,~ /Y~R3 and their salts with physiologically acceptable acids, which due to their pharmacoloyical properties cal1 be used as medicaments.
In the formula I, R1 and R2, which may be identical or different, are hydrogen, halogen, alkyl or alkoxy having from 1 to 4 carbon atoms, nitro or amino, R3 is hydrogen, a saturated or unsaturated, linear or branched a].kyl radical having from 1 to 8 carbon atoms, or a cycloalkyl radical having from 5 to 8 ca~.bon atoms;
the alkyl or cycloalkyl radical in turn may be substituted by a phenyl radical or a phenyl radical which may be mono~
or disubstituted by halogen, nitro, ami.no or alkyl or alkoxy having from 1 to 4 carbon atoms.
Preferred are those compounds of the formula I, in which R1 and R2 are identical or different and represent hydrogen, chlorine, fluorine, methyl or methoxy, and R3 is hydrogen or an alkyl chain having from 1 to 4 carbon atoms, which in turn may be substituted by phenyl optionally mono- or disubstituted by ch]orine, fluori.ne, methyl, methoxy, nitro or amino.
30- Especially preferred are those compounds of the formula I, in which R1 is hydrogen and R2 is chlorine, fluorine, me-thyl or me-thoxy,or R1 and R2 each are metl1oxy, and R3 is hydrogen or an al~yl chaill having from 1 to 4 carbon atoms, which in turn may be suhstituted by phenyl optionally mono- or dlsubstituted by chlol^irle, fluorine, methyl or methoxy .
.,, , , ~
~93~06
- 3- OE 8?/F 025 The compounds of the formula I according to the in-ven-tion are novel substances. In animal tests, they inhibit the secretion of ~astri..c acid stimulated by penta~astrin and are therefore medi.caments for the prevention and therapy of gastric ulcers. Furthermore, they serve as intermediates for the synthesis of novel medicaments.
Subject of the invention is also a process for the preparation of compounds of the formula I, which comprises reacting an aminopyrroline of the formula II with hydrazine or its hydrate to give a compound of the formula I
~R3 ~ ~ ~ }~
R1 ~ L ~ ~ R 1~
~\1~ ~\~/ '1~\ R3 O NH2 ~ N-l (II) (I~
in ~hich formulae R1 throu~h R3 are as defined ahove sub formula I, and if desired, converting a compound of the formula I in which R3 i.s benzyl to a compound of the formula I in which R3 is hydrogen by splitting off the benzyl group.
Generally, 1,3-di.carbonyl compounds or the derivatives thereof~ e.g. B-aminovinylketones, are smoothly cyclized to the corresponding pyrazole derivatives (A.N. Kost, I.I.
Grandberg, Advances in ~leterocycli.c Chemistry, Edited by A.R. Katritzky, A.J. Boulton, Vol. 6, p. 358 et seq .
Academic Press, New York, London 1966). In the present case, therefore, pyrrolo-/ 3,~~c_7-pyrazoles (IIa~ would be expected to be formed. However, it was surprising to obser.ve that on reaction of II with a hydrazine compound I
are obtained which difer from those initi.ally expected by an additionai reduction step in which the pyrroline ring of the starting material is opened.
3~
~ 4 - HOE 8?/F 025_ R1 ~ IIa The starting substances of the formula II are novel eompounds, and they are synthetized according to the following methods:
By reaction with substituted 3-aminopropionic acid nitri]es IV, the aminoketones V are prepared from substi-tuted phenacyl halides III, in which formulae R1 through R3 are as defined sub formula I, and X is halogen, especially chlorine or bromine.
R3-N-C~12-C~I2-C~ ~R1 j~ ~ce~
(III) (I~) (V) The eompounds IV are obtained by Michael addition of amines (R3-NH2) to equimolar amounts of acrylonitrile in methanol.
The conversion to compounds V is advantageously carried out in an inert solvent sueh as eth~r, ac.~etone or a ehlorinated hyclrocarbon, for example methylene chloride;
the reaetion temperature beiny in a range of from ~30 to C ~
The hydrogen halide formed in the reaction of III
to IV is advanta~eous'.y absorbed by a suitable base.
Especial]y suitable are tertiary amines which are unfit for quaternization with III. Suitable amines are for example 1,4~diaza-bieyelo/ 2,2,2 7Octane, 1,5-diaza-bieyelo/ 4,3,0_7non~5-ene or N,N-di.isopropylet.hy].amine. The most simple method consists howevel^ in usiny a double excess of amine IV. In the ease whe.re R3 is hydroyen, a 3~
- 5 - HOR 82/F 025_ mixture of 3-ami.nopropionic acid nitril.e ~IV, R -- H) and one of the above acid-binding agents, for example in a solvent as indicated above, is advantageously intro-duced first into the reaction vessel and the phenacyl halide, dissolved in the same solvent, is added dropwise at temperatures of below 5-8~C.
The compounds V may alternatively be usec1. in crude form for the subsequent cyclization to the compounds II, so that their purification by crystallization or distillation can be omitted.
Cyclization of V to II is generally carried out in a basic medium by treating a compound V in an appropriate alcohol such as methanol, ethanol, isopropanol or tert.-butyl alcohol with a corresponding alkali metal a]coholate, preferably sodium alcoholate. The reaction temperature is .. from -20C to the reflux temperature of the reaction mixture. The reacti.on being complete, the product can.be isolated by adc1ing water.
Alternatively, cyclization is possihle under acidic conditions; the use of a Lewis acid such as aluminum chloride or boron trifluoride beiny recommended in this case. For exa~.ple, a compound V is introduced with cooling into boron trifluoricle etherate, and depending on the substituents the reaction solution is maintained at a .25. temperature of from -10C to the reflux temperatu~e of the reaction mixture until the reaction is complete. By addition of water, the compounds VI c.ry~tallize in cold state, or they can be separated by extraction us:ing an organic .solvent.
Y~ ~ ? ~ ]:T
V VI `' . .
~ 3~3~)6 - 6 - _OE e2,~ 025 By treatin(, th~ compound VI obtained with aqueous alka~is such as a solution o~ sodium hydroxide, amrnonia or bicarbonate, it is easily split hydrolytica]ly to give a compound II.
This process of acid cyclization is particularly recommended in the case where R1 and R2 are metlloxy -substituents.
For convertin~ the compounds II to I, they are treated suitably with hydrazine hydrate. ~dvantageous are reflux temperatures in hydrazine hydrate or alcoholic solutions. Suitable alcohols are primary alcoho]s such as methanol or ethanol, secondary alco}lols such as isopropanol, or tertiary alcohols such as tert.-butanol. The conversion to compound I may also be performed with hydrazine in glacial acetic acid.
The reaction being complete, the reaction mixture is concentrated and the compound I is isolated in accordance with its basic character by converting it to a water-soluble salt by adding a mineral acid, extractin~ the aqueous salt solution with a water-immiscible solvent in order to remove neutral impurities, and therl liberating the base again by adjusting the pH of the water phase in the alkaline range. Alternatively, the compound I may be precipitated by adding water, or extracted by means of an organic water~immiscible solvent.
The optional sp]itting-off of a benzyl group may be carried out as follows:
Especially advantageous is the hydrogeno1ytic splitting in the presence of Raney nickel in an acidic medium. Other methods may be applied alternatively, for example sp]itting with elementary sodium in ]iquid ammonia, or treatment with tetra]in (or another easily oxidizable hydrocarbon splittLng off hydrogen] in the presence of a noble metal catalyst, -for c-~xample pa]ladium on charcoal, at elevated temperature, especially at 110-1~0C.
The compounds of the :invellt:ion have va]uable pharma--cological properties. In animal tests, they inhikit the ~ ~.9;~,V6 -- 7 ~ ~IOE ~2/F 025 secretion of gastric acid. They are therefore suitable as medicaments Eor the prevention and therapy of gastric ulcers.
The novel compounds can be administered as medicaments either per se or in admixture witth physiologically tolerated auxiliaries or carrier materials. For oral administration the compounds of the formnla I are mixed with the usual substances and transformed according to customary methods into the usual forms of adrninistration, for example tablets, push-fit capsules, aqueous, alcoholic or oily suspensions or aqueous, alcoholic or oily solutions.
Suitable inert carrier materials are, for example, magnesium carbonate, lactose or corn starch. For tab1ets, the compounds can be formulated as dry or moist granules.
As oily carriers or solvents especially vegetable and mineral oils can be used, for example sunflower oil, olive - oil or paraffin oil.
For intravenous application, the active compounds or the salts thereof with physiologically tolerable organic or inorganic acids are dissolved in substances customary for this purpose. Examples of organic acids are acetic~ propionic, lactic, malonic, succinic, maleic, fumaric, citric, malic, tartaric, benzoic, o}~yethane--sulfonic, aceturic (acetylaminoacetic), ethylenediamine-tetraace-tic, embonic (1,1~-methylene-bis-(2-hydroxy-3-` naphthoic)) acid, and synthetic resins con.aining acidic groups. Examples of inorganic acids are hydroIlalic acids such as hydrochloric or hydrobromic acid, sulflIric, phosphoric and amidosulfonic acid.
Suitable solvents for intravenous administration are, for example, water, physiological sodium chloride solution, which can be provided with furt-her additives such as alcohols, (for ex~ propanediol or glycerol), or sugar solutions, (for ex~ ylucose or mannitol solutions).
The fol]owing Exarnp]es illustrate the invention.
3~
Example I
5-(2-i~.ethylaminoethyl)~ pyrazole a) N-Methyl-N-(2-p~yl-2-_xo-ethyl)-3-am _ propion~e_ acid nitrile 0.1 Mol of phenacylbromide is dissolved in 100 ml of acetone, and 0.2 mol of 3-methylamlnopropionic acid nitrile, dissolved in 50 ml of acetone, is added at 0C.
The batch is stirred for 15 hours at room tempexature, the solution is filtered off from undissolved ammonium salt, and concentrated. The crude product is sufficiently pure for the further reaction.
b) 3-Amino-2-benzo~l-1-methyl-~-~d:~,g,~lL~rrole 0.1 ~ol of N~methyl-N-(2-phenyl-2-oxo-e-thyl~-3-amino--propionic acid nitrile 1s dissolvecl in 200 ml of rrlethano].
After addition of 0.3 mol of sodium methylate, the - mixture is refluxed for 2 hours. Subsequent]y, the reaction mix-ture is poured on-to 800 ml of a mixture of iee and water, extracted with methylene chloride, the organic phase is dried and concentrated. The remaining oil crystallizes slowly (m.p. 115-117C), and it is sufficiently pure for the further reaction.
-c) 5-(2-Methylaminoethyl-3-phenyl-pyrazole 0.03 Mol of 3-amino-2-benzoyl~ methyl-~,5-dihydro-pyrrole in 50 ml of ethanol are refluxed for 4 hours a~ter having added 8 ml of hydrazine hydrate. Subsequently, the reaction mixture is pouxed onto 200 ml of water, and extrac-~ed with ethyl acetate. After drying and concen-tration of the orgaIlic phase, an oily crude product is obtained which is convertect to the salt with oxalic acid.
M.p. 137C (oxala-te).
Example 2 - 5-(2-Benzylamino~thyl)-3-~heny~ ~razole _ _ . . .
-a)-N-Benzyl-N-(2-~ _ny__2-oxo--e-thyl)-3-aminopropio~ ac:~d nitrile Aceording to Example 1a irom phenacylbromide and 3-benzylaminopropionic acid nitrile. Crude product reactecl further.
~9~3~6 b) 3-Amino-2-benz.oyl~ benz~4,5-~di~o-pyr.role According to ~xamplc lb from N--benzyl-N-(2-phenyl-2-oxc>-e-thyl)-3--aminopropionic acid nitrile.
m.p.: 149-150C (diethyl ether) 5 c) 5-(2-Be zylaminoethyl)-3=phelly -~yrazcle According to Example 1c from 3-amino-2-benzoyl-1-benzyl-4,5-dihydro-pyr.role and hydrazine in methano]
m.p.: 109C (free base) 213-215C (hydrochlori.de) Example 3 5-(2-Benzylaminoethy )-3-(3,4-dimetho~yphenyl)-~y_a%ole a)- N-Benzyl-N-/ 2-(3!4--dimethoxyphenyl)-2-oxo-ethyl_7-3-_ aminopropionic ac d nltrile_ Corresponding to Example 1a from 3,4-dimethoxy-phenacylbromide and 3-benzylaminopropionic acid nitrile.
- 15 m.p.: 79-82C (diethyl ether) ' b)''1-Benzyl--7-(3,4-dimethoxyphe_~1)-5,5-difluor.o-2,3-_ dihydro-6-oxa-4-azonia-5-borato-indole 0.1 Mol c~f N-benzyl--N-/ 2-(3,4-dirnethoxypheny].)-2-oxo-ethyl_7-3-amino-propionic acid nitrile in 100 ml of boron .20 trifluoride etherate is maintained for 16 hours at 90-9SC. The reaction mixture is then poured onto ice, adjusted to neutral wit:h aqueous an~monia solution, and extracted with ethyl ace-tate. After drying and concen-tration of the organ.ic phase an oil is obtained which is 25 crystallized from isopropanol.
M.p. 175-176C.
-c) 3-Ami.no-1-benæyl~2-(3,4--dime-lhoxyben7oyl)-4,5--dil-1~^o pyrro]e 0.05 Mol of the compound prepared according to 30 Example 3b is suspended in 100 Ml of concentrated aqueous sodium hydroxide solution, and stirred for 24 hours at room temperature. The precipitate is suction-:E'iltered, . . washed to neutral and the filter cake is dried.
M.p. 134-136C.
~ 33~06 - 10 -- HO _82/F 025 d) 5-(2-senzy]aminoeth~-3-(3~4-dimetho~x~hen~)-p~ra%ole __ _ ___ ___ From 3-amino~ benzyl-2-(3,4-dimethoxybenzoyl)-4,5~
dihydropyrrole by treatment with hydrazine in t.-hutanol accordinc~ to Example 1c.
Example 4 ' 5-/ 2-(2-Chlorobel~y~amino)-ethyl_7-3-phenyl-pyrazole a) N-(2-Chlorobenzyl)-N-(2~phenyl-2-oxo-ethyl)-3-amino-propionic acid nitrile.
From 1 mol of phenacylbxomide and 1 mol o~ 3-(2 chloroberlzy:Lamino)-propionic acid nitrile accordin~ to Example 1a with 1 mol of N,N-diisopropyl-e-thylamine a~
acid acceptor. The crude product was reacted further.
b) 3-Amino~-2~benzoyl-1-(2-chlorobenzyl-4,5-dihy~lro-pyrrole.
From N-(2-chlorobenzyl)-N-(2-phenyl-2-oxo-ethyl)-3-amino-propionic acid nitrile by treatment with methylate according to Examp],e 1b.
m.p.: 151C.
c) 5-/ 2-(2~-Chlorobelizylamino)-ethyl_7-3--phenyl -pyrazole.
From 3-amino-2-benzoyl-1-(2-chlorobenzyl)-4,5-dihydro-pyrrole by treatment with hydrazine in methancl accordins to Example 1c.
m.p.: 206-207~C (HCl) ~ le 5 S-/ 2-(4-Meth~ _zy~_mino)-ethyl 7-3-phe~ yrazole a) N-(4-Methylbenzyl)-N-(2~phellyl-2-oxo~ethyl)-3-amino-propionic aci~ nitrile From phenacylbromidc and 3-(4-methylbenzylamino)-propionic acid nitrile according to Example 1a.
b) 3-~Amino--2-benzoyl-1-(4-methylbenzyl)-4,5-dihydro-pyrrole.
From N-(4-rnetllylbenzyl)-N-(2-pllerlyl-2-oxo--ethyl)-3-amino-prcpionic acid nitrile by treatment with methylate according to Example 1b.
~'33~
~ E1OE 82/F_025 c) 5-/ 2-(4-Methylbenzylamino)-ethyl_ 7 - 3-phenyl~
pyrazole.
From 3-amino-2-benzoyl-1-~4-methylbenzy])-4,S-dihydro-pyrrole by t~eatment ~7ith hydrazine in isopropanol according to Example 1c.
Example 6 5-[2~ Methoxybenzylami.no)-ethyl]-3--phenyl~p~_ zole a) N-(3-Methoxybenzy])-N-(2-phenyl-2-oxo--ethyl)-3--amino-propionic acid nitrile.
From 1 mol of phenacylbromide and 1 mol of 3-~3-methoxybenzyl-amino)-propionic acid nitri]e according l.o Example 1a, wi.th 1 mol of N,N-diisopropylethylamine as acid acceptor.
b) 3-Amino-2-benzoyl-1-(3-methoxybenzyl)-4,5-dihydro-pyrazole.
From N-(3-methoxybenzyl)-N-(2-phenyl-2-oxo-ethyl)-3 aminopropionic acid nitrile by treatment with methylate accQr~in~ to Example 1b.
c) 5-[2-(3-Methoxybenzylamino)-ethyl]-3-phenyl-pyrazole From 3-amino-2-bellzoyl-1-(3-methoxyhenzyl)-4,5-dihydro-pyrrole by treatment with hydrazine in methanol according to Example 1c.
m.p.: 195C (oxalate) E mple 7_ _ 5-[2-(3,4-Dim~thox~b_nzy mi.no)-e'chyl]--3--phen~
pyrazole a) N-(3,4--Dimethoxybenzyl)-N-(2-phenyl-2-oxo-ethyl)-3-amino-propionic acid nitril.e.
From phenacylbrolni.de and 3-(3,4--dimetho.Yyber)Y.yl~mino)-propi.onic acid nitrile accord.irlg to Example 1a.
b) 3-Amino-2-benzoyl-1-(3,4-dimethoxyben7.yl)-4,5-di.hyclro--pyrrole.
From N-(3,4-dilrlethoxyphenyl)-N-~2-phenyl-2-oxc)-ethyl)-3~amino--propion-c acid nitrile by 'creatment with methylate according to Exalnple 1b~
3~;~)6 ,i - 12 - HOE _ /F ~5 .~
c) 5-[2-(3,~-Dimethoxybenzylamino)-ethyl]-3-pheny]-pyrazole From 3-amino-2-benzoyl-1-(3,4--dimethoxybenzyl~-~,5-dihydro-pyrrole by treatrnellt with hydrazine in ethanol according to ~xample 1c.
Example 3 _ _ - 5-[2-(2-Phe_ylethLl m no)-etl~ 3-phenyl-pyrazole a) N-(2-Phenylethyl)-N-(2-phenyl-2--oxo-ethy])~3-amino-propionic acid nitrile.
From phenacylbromide and 3--(2-phenylethylamino)-propionic acid nitrile according to Example 1a.
b) 3-tlmino-2-benzoyl-1-(2-phenylethyl)-4,5-dihydro-pyrrole From N-(2-phenylethyl)-N-(2-phenyl-2-oxo-etllyl)-3-amino-propionic acid nitrile by treatment with methylate accordir.g to Example 1b.
c) 5-[2-(2-Pheny]ethylamino)-ethyl]-3-phenyl-pyrazole From 3-amino-2-benzoyl-1-(2-phenylethyl)-~,5-dihydro-pyrrole by treatment with hydrazine in ethanol corres-ponding to Example 1c.
Example 9 5-[2-(3-Phenylpropylami_o)-ethyl] _-~henyl-pyrazole a) N-(3-Phenylpropyl)-N-(2-phenyl-2-oxo-ethyl)-3-, amino-propionic acid nitrile.
From 1 mol of phenacy]bromide and 1 mol of 3-(3-phenyl-propylamino)-propionic acid nitrile accordillc~ to Example 1a, with 1 mol of N,N-diisopropyl-ethylalnine as acid acceptor.
b) 3-Amino-2-benzoyl-1-(3-phenylpropyl)-4,5-dihydro-pyrrole From N-(3--phenylpropyl)-N-(2-phenyl-2 oxo-ethyl)-3-amino-propionic acld nitrile by treatment Witll methylate according to Exarlple 1b.
c) 5-[2-(3-Phenylpropylamino)-et'ny:L]-3-phenyl~
pyrazole .
~L~
- 13 E~OE 82/F _025 From 3-t;m:ino-2-belzoyl-1-(3-pheny]propyl)--4,5-dihydro-pyrro].e by tr~atment with hydra.~ine in i.sopropanol aeeordin~ to Examp]e 1e.
Example 1 0 5-[2-Benzy].amino_ethyll-3--~4-ehlorophenyl~~eyrazol_ a) N-Benzyl-N-(2-(4-chloropllenyl)-2-oxo-ethyl)-3-arnino-propionie aeid nitrile From 4-ehlorophenacylbromide and 3-(benzylamino)--propionie acid ni-trile according -to Exampl.e 1a.
b) 3-Amino-2-(4-chlorohenzoyl)-1~benzyl-4,5-dlhydro-pyrrole From N-(senzyl)-N~(2-(4-chlorophenyl)-2-os~o-~thyl)-3-amino-propionic aeid nitrile by treatment with methylate . aeeording to Example 1b.
e) 5-[2-Benzylamino-ethyl]-3-(4-ehlorophenyl)-pyrazole From 3-amino-2-(4-chlorobenzoyl)-1-benzyl 4,5-dihydro-pyrrole by treatment with hydrazine in ethanol aceording to Example 1c.
m.p.: 182-184C (HCl) Example 11_ 5-[2-(Chlorobenzylamino)-ethyl-3- 4-chlorophenyl) _ pyrazole a) N-(2-Chlorobenzyl)-N-[2-(4-ehlorophenyl)-2-oxo' ethyl]-3-amino-propionie acid ni-trile From 4-chlorophenacylbromide and 3-(2-chlorobenzylamino~-propionie acid nitri.le aceording to Example 1a.
b) 3--Amino 2-l4-ehlorohenzoyl)-1-(2-chloroberlzyl)-
Subject of the invention is also a process for the preparation of compounds of the formula I, which comprises reacting an aminopyrroline of the formula II with hydrazine or its hydrate to give a compound of the formula I
~R3 ~ ~ ~ }~
R1 ~ L ~ ~ R 1~
~\1~ ~\~/ '1~\ R3 O NH2 ~ N-l (II) (I~
in ~hich formulae R1 throu~h R3 are as defined ahove sub formula I, and if desired, converting a compound of the formula I in which R3 i.s benzyl to a compound of the formula I in which R3 is hydrogen by splitting off the benzyl group.
Generally, 1,3-di.carbonyl compounds or the derivatives thereof~ e.g. B-aminovinylketones, are smoothly cyclized to the corresponding pyrazole derivatives (A.N. Kost, I.I.
Grandberg, Advances in ~leterocycli.c Chemistry, Edited by A.R. Katritzky, A.J. Boulton, Vol. 6, p. 358 et seq .
Academic Press, New York, London 1966). In the present case, therefore, pyrrolo-/ 3,~~c_7-pyrazoles (IIa~ would be expected to be formed. However, it was surprising to obser.ve that on reaction of II with a hydrazine compound I
are obtained which difer from those initi.ally expected by an additionai reduction step in which the pyrroline ring of the starting material is opened.
3~
~ 4 - HOE 8?/F 025_ R1 ~ IIa The starting substances of the formula II are novel eompounds, and they are synthetized according to the following methods:
By reaction with substituted 3-aminopropionic acid nitri]es IV, the aminoketones V are prepared from substi-tuted phenacyl halides III, in which formulae R1 through R3 are as defined sub formula I, and X is halogen, especially chlorine or bromine.
R3-N-C~12-C~I2-C~ ~R1 j~ ~ce~
(III) (I~) (V) The eompounds IV are obtained by Michael addition of amines (R3-NH2) to equimolar amounts of acrylonitrile in methanol.
The conversion to compounds V is advantageously carried out in an inert solvent sueh as eth~r, ac.~etone or a ehlorinated hyclrocarbon, for example methylene chloride;
the reaetion temperature beiny in a range of from ~30 to C ~
The hydrogen halide formed in the reaction of III
to IV is advanta~eous'.y absorbed by a suitable base.
Especial]y suitable are tertiary amines which are unfit for quaternization with III. Suitable amines are for example 1,4~diaza-bieyelo/ 2,2,2 7Octane, 1,5-diaza-bieyelo/ 4,3,0_7non~5-ene or N,N-di.isopropylet.hy].amine. The most simple method consists howevel^ in usiny a double excess of amine IV. In the ease whe.re R3 is hydroyen, a 3~
- 5 - HOR 82/F 025_ mixture of 3-ami.nopropionic acid nitril.e ~IV, R -- H) and one of the above acid-binding agents, for example in a solvent as indicated above, is advantageously intro-duced first into the reaction vessel and the phenacyl halide, dissolved in the same solvent, is added dropwise at temperatures of below 5-8~C.
The compounds V may alternatively be usec1. in crude form for the subsequent cyclization to the compounds II, so that their purification by crystallization or distillation can be omitted.
Cyclization of V to II is generally carried out in a basic medium by treating a compound V in an appropriate alcohol such as methanol, ethanol, isopropanol or tert.-butyl alcohol with a corresponding alkali metal a]coholate, preferably sodium alcoholate. The reaction temperature is .. from -20C to the reflux temperature of the reaction mixture. The reacti.on being complete, the product can.be isolated by adc1ing water.
Alternatively, cyclization is possihle under acidic conditions; the use of a Lewis acid such as aluminum chloride or boron trifluoride beiny recommended in this case. For exa~.ple, a compound V is introduced with cooling into boron trifluoricle etherate, and depending on the substituents the reaction solution is maintained at a .25. temperature of from -10C to the reflux temperatu~e of the reaction mixture until the reaction is complete. By addition of water, the compounds VI c.ry~tallize in cold state, or they can be separated by extraction us:ing an organic .solvent.
Y~ ~ ? ~ ]:T
V VI `' . .
~ 3~3~)6 - 6 - _OE e2,~ 025 By treatin(, th~ compound VI obtained with aqueous alka~is such as a solution o~ sodium hydroxide, amrnonia or bicarbonate, it is easily split hydrolytica]ly to give a compound II.
This process of acid cyclization is particularly recommended in the case where R1 and R2 are metlloxy -substituents.
For convertin~ the compounds II to I, they are treated suitably with hydrazine hydrate. ~dvantageous are reflux temperatures in hydrazine hydrate or alcoholic solutions. Suitable alcohols are primary alcoho]s such as methanol or ethanol, secondary alco}lols such as isopropanol, or tertiary alcohols such as tert.-butanol. The conversion to compound I may also be performed with hydrazine in glacial acetic acid.
The reaction being complete, the reaction mixture is concentrated and the compound I is isolated in accordance with its basic character by converting it to a water-soluble salt by adding a mineral acid, extractin~ the aqueous salt solution with a water-immiscible solvent in order to remove neutral impurities, and therl liberating the base again by adjusting the pH of the water phase in the alkaline range. Alternatively, the compound I may be precipitated by adding water, or extracted by means of an organic water~immiscible solvent.
The optional sp]itting-off of a benzyl group may be carried out as follows:
Especially advantageous is the hydrogeno1ytic splitting in the presence of Raney nickel in an acidic medium. Other methods may be applied alternatively, for example sp]itting with elementary sodium in ]iquid ammonia, or treatment with tetra]in (or another easily oxidizable hydrocarbon splittLng off hydrogen] in the presence of a noble metal catalyst, -for c-~xample pa]ladium on charcoal, at elevated temperature, especially at 110-1~0C.
The compounds of the :invellt:ion have va]uable pharma--cological properties. In animal tests, they inhikit the ~ ~.9;~,V6 -- 7 ~ ~IOE ~2/F 025 secretion of gastric acid. They are therefore suitable as medicaments Eor the prevention and therapy of gastric ulcers.
The novel compounds can be administered as medicaments either per se or in admixture witth physiologically tolerated auxiliaries or carrier materials. For oral administration the compounds of the formnla I are mixed with the usual substances and transformed according to customary methods into the usual forms of adrninistration, for example tablets, push-fit capsules, aqueous, alcoholic or oily suspensions or aqueous, alcoholic or oily solutions.
Suitable inert carrier materials are, for example, magnesium carbonate, lactose or corn starch. For tab1ets, the compounds can be formulated as dry or moist granules.
As oily carriers or solvents especially vegetable and mineral oils can be used, for example sunflower oil, olive - oil or paraffin oil.
For intravenous application, the active compounds or the salts thereof with physiologically tolerable organic or inorganic acids are dissolved in substances customary for this purpose. Examples of organic acids are acetic~ propionic, lactic, malonic, succinic, maleic, fumaric, citric, malic, tartaric, benzoic, o}~yethane--sulfonic, aceturic (acetylaminoacetic), ethylenediamine-tetraace-tic, embonic (1,1~-methylene-bis-(2-hydroxy-3-` naphthoic)) acid, and synthetic resins con.aining acidic groups. Examples of inorganic acids are hydroIlalic acids such as hydrochloric or hydrobromic acid, sulflIric, phosphoric and amidosulfonic acid.
Suitable solvents for intravenous administration are, for example, water, physiological sodium chloride solution, which can be provided with furt-her additives such as alcohols, (for ex~ propanediol or glycerol), or sugar solutions, (for ex~ ylucose or mannitol solutions).
The fol]owing Exarnp]es illustrate the invention.
3~
Example I
5-(2-i~.ethylaminoethyl)~ pyrazole a) N-Methyl-N-(2-p~yl-2-_xo-ethyl)-3-am _ propion~e_ acid nitrile 0.1 Mol of phenacylbromide is dissolved in 100 ml of acetone, and 0.2 mol of 3-methylamlnopropionic acid nitrile, dissolved in 50 ml of acetone, is added at 0C.
The batch is stirred for 15 hours at room tempexature, the solution is filtered off from undissolved ammonium salt, and concentrated. The crude product is sufficiently pure for the further reaction.
b) 3-Amino-2-benzo~l-1-methyl-~-~d:~,g,~lL~rrole 0.1 ~ol of N~methyl-N-(2-phenyl-2-oxo-e-thyl~-3-amino--propionic acid nitrile 1s dissolvecl in 200 ml of rrlethano].
After addition of 0.3 mol of sodium methylate, the - mixture is refluxed for 2 hours. Subsequent]y, the reaction mix-ture is poured on-to 800 ml of a mixture of iee and water, extracted with methylene chloride, the organic phase is dried and concentrated. The remaining oil crystallizes slowly (m.p. 115-117C), and it is sufficiently pure for the further reaction.
-c) 5-(2-Methylaminoethyl-3-phenyl-pyrazole 0.03 Mol of 3-amino-2-benzoyl~ methyl-~,5-dihydro-pyrrole in 50 ml of ethanol are refluxed for 4 hours a~ter having added 8 ml of hydrazine hydrate. Subsequently, the reaction mixture is pouxed onto 200 ml of water, and extrac-~ed with ethyl acetate. After drying and concen-tration of the orgaIlic phase, an oily crude product is obtained which is convertect to the salt with oxalic acid.
M.p. 137C (oxala-te).
Example 2 - 5-(2-Benzylamino~thyl)-3-~heny~ ~razole _ _ . . .
-a)-N-Benzyl-N-(2-~ _ny__2-oxo--e-thyl)-3-aminopropio~ ac:~d nitrile Aceording to Example 1a irom phenacylbromide and 3-benzylaminopropionic acid nitrile. Crude product reactecl further.
~9~3~6 b) 3-Amino-2-benz.oyl~ benz~4,5-~di~o-pyr.role According to ~xamplc lb from N--benzyl-N-(2-phenyl-2-oxc>-e-thyl)-3--aminopropionic acid nitrile.
m.p.: 149-150C (diethyl ether) 5 c) 5-(2-Be zylaminoethyl)-3=phelly -~yrazcle According to Example 1c from 3-amino-2-benzoyl-1-benzyl-4,5-dihydro-pyr.role and hydrazine in methano]
m.p.: 109C (free base) 213-215C (hydrochlori.de) Example 3 5-(2-Benzylaminoethy )-3-(3,4-dimetho~yphenyl)-~y_a%ole a)- N-Benzyl-N-/ 2-(3!4--dimethoxyphenyl)-2-oxo-ethyl_7-3-_ aminopropionic ac d nltrile_ Corresponding to Example 1a from 3,4-dimethoxy-phenacylbromide and 3-benzylaminopropionic acid nitrile.
- 15 m.p.: 79-82C (diethyl ether) ' b)''1-Benzyl--7-(3,4-dimethoxyphe_~1)-5,5-difluor.o-2,3-_ dihydro-6-oxa-4-azonia-5-borato-indole 0.1 Mol c~f N-benzyl--N-/ 2-(3,4-dirnethoxypheny].)-2-oxo-ethyl_7-3-amino-propionic acid nitrile in 100 ml of boron .20 trifluoride etherate is maintained for 16 hours at 90-9SC. The reaction mixture is then poured onto ice, adjusted to neutral wit:h aqueous an~monia solution, and extracted with ethyl ace-tate. After drying and concen-tration of the organ.ic phase an oil is obtained which is 25 crystallized from isopropanol.
M.p. 175-176C.
-c) 3-Ami.no-1-benæyl~2-(3,4--dime-lhoxyben7oyl)-4,5--dil-1~^o pyrro]e 0.05 Mol of the compound prepared according to 30 Example 3b is suspended in 100 Ml of concentrated aqueous sodium hydroxide solution, and stirred for 24 hours at room temperature. The precipitate is suction-:E'iltered, . . washed to neutral and the filter cake is dried.
M.p. 134-136C.
~ 33~06 - 10 -- HO _82/F 025 d) 5-(2-senzy]aminoeth~-3-(3~4-dimetho~x~hen~)-p~ra%ole __ _ ___ ___ From 3-amino~ benzyl-2-(3,4-dimethoxybenzoyl)-4,5~
dihydropyrrole by treatment with hydrazine in t.-hutanol accordinc~ to Example 1c.
Example 4 ' 5-/ 2-(2-Chlorobel~y~amino)-ethyl_7-3-phenyl-pyrazole a) N-(2-Chlorobenzyl)-N-(2~phenyl-2-oxo-ethyl)-3-amino-propionic acid nitrile.
From 1 mol of phenacylbxomide and 1 mol o~ 3-(2 chloroberlzy:Lamino)-propionic acid nitrile accordin~ to Example 1a with 1 mol of N,N-diisopropyl-e-thylamine a~
acid acceptor. The crude product was reacted further.
b) 3-Amino~-2~benzoyl-1-(2-chlorobenzyl-4,5-dihy~lro-pyrrole.
From N-(2-chlorobenzyl)-N-(2-phenyl-2-oxo-ethyl)-3-amino-propionic acid nitrile by treatment with methylate according to Examp],e 1b.
m.p.: 151C.
c) 5-/ 2-(2~-Chlorobelizylamino)-ethyl_7-3--phenyl -pyrazole.
From 3-amino-2-benzoyl-1-(2-chlorobenzyl)-4,5-dihydro-pyrrole by treatment with hydrazine in methancl accordins to Example 1c.
m.p.: 206-207~C (HCl) ~ le 5 S-/ 2-(4-Meth~ _zy~_mino)-ethyl 7-3-phe~ yrazole a) N-(4-Methylbenzyl)-N-(2~phellyl-2-oxo~ethyl)-3-amino-propionic aci~ nitrile From phenacylbromidc and 3-(4-methylbenzylamino)-propionic acid nitrile according to Example 1a.
b) 3-~Amino--2-benzoyl-1-(4-methylbenzyl)-4,5-dihydro-pyrrole.
From N-(4-rnetllylbenzyl)-N-(2-pllerlyl-2-oxo--ethyl)-3-amino-prcpionic acid nitrile by treatment with methylate according to Example 1b.
~'33~
~ E1OE 82/F_025 c) 5-/ 2-(4-Methylbenzylamino)-ethyl_ 7 - 3-phenyl~
pyrazole.
From 3-amino-2-benzoyl-1-~4-methylbenzy])-4,S-dihydro-pyrrole by t~eatment ~7ith hydrazine in isopropanol according to Example 1c.
Example 6 5-[2~ Methoxybenzylami.no)-ethyl]-3--phenyl~p~_ zole a) N-(3-Methoxybenzy])-N-(2-phenyl-2-oxo--ethyl)-3--amino-propionic acid nitrile.
From 1 mol of phenacylbromide and 1 mol of 3-~3-methoxybenzyl-amino)-propionic acid nitri]e according l.o Example 1a, wi.th 1 mol of N,N-diisopropylethylamine as acid acceptor.
b) 3-Amino-2-benzoyl-1-(3-methoxybenzyl)-4,5-dihydro-pyrazole.
From N-(3-methoxybenzyl)-N-(2-phenyl-2-oxo-ethyl)-3 aminopropionic acid nitrile by treatment with methylate accQr~in~ to Example 1b.
c) 5-[2-(3-Methoxybenzylamino)-ethyl]-3-phenyl-pyrazole From 3-amino-2-bellzoyl-1-(3-methoxyhenzyl)-4,5-dihydro-pyrrole by treatment with hydrazine in methanol according to Example 1c.
m.p.: 195C (oxalate) E mple 7_ _ 5-[2-(3,4-Dim~thox~b_nzy mi.no)-e'chyl]--3--phen~
pyrazole a) N-(3,4--Dimethoxybenzyl)-N-(2-phenyl-2-oxo-ethyl)-3-amino-propionic acid nitril.e.
From phenacylbrolni.de and 3-(3,4--dimetho.Yyber)Y.yl~mino)-propi.onic acid nitrile accord.irlg to Example 1a.
b) 3-Amino-2-benzoyl-1-(3,4-dimethoxyben7.yl)-4,5-di.hyclro--pyrrole.
From N-(3,4-dilrlethoxyphenyl)-N-~2-phenyl-2-oxc)-ethyl)-3~amino--propion-c acid nitrile by 'creatment with methylate according to Exalnple 1b~
3~;~)6 ,i - 12 - HOE _ /F ~5 .~
c) 5-[2-(3,~-Dimethoxybenzylamino)-ethyl]-3-pheny]-pyrazole From 3-amino-2-benzoyl-1-(3,4--dimethoxybenzyl~-~,5-dihydro-pyrrole by treatrnellt with hydrazine in ethanol according to ~xample 1c.
Example 3 _ _ - 5-[2-(2-Phe_ylethLl m no)-etl~ 3-phenyl-pyrazole a) N-(2-Phenylethyl)-N-(2-phenyl-2--oxo-ethy])~3-amino-propionic acid nitrile.
From phenacylbromide and 3--(2-phenylethylamino)-propionic acid nitrile according to Example 1a.
b) 3-tlmino-2-benzoyl-1-(2-phenylethyl)-4,5-dihydro-pyrrole From N-(2-phenylethyl)-N-(2-phenyl-2-oxo-etllyl)-3-amino-propionic acid nitrile by treatment with methylate accordir.g to Example 1b.
c) 5-[2-(2-Pheny]ethylamino)-ethyl]-3-phenyl-pyrazole From 3-amino-2-benzoyl-1-(2-phenylethyl)-~,5-dihydro-pyrrole by treatment with hydrazine in ethanol corres-ponding to Example 1c.
Example 9 5-[2-(3-Phenylpropylami_o)-ethyl] _-~henyl-pyrazole a) N-(3-Phenylpropyl)-N-(2-phenyl-2-oxo-ethyl)-3-, amino-propionic acid nitrile.
From 1 mol of phenacy]bromide and 1 mol of 3-(3-phenyl-propylamino)-propionic acid nitrile accordillc~ to Example 1a, with 1 mol of N,N-diisopropyl-ethylalnine as acid acceptor.
b) 3-Amino-2-benzoyl-1-(3-phenylpropyl)-4,5-dihydro-pyrrole From N-(3--phenylpropyl)-N-(2-phenyl-2 oxo-ethyl)-3-amino-propionic acld nitrile by treatment Witll methylate according to Exarlple 1b.
c) 5-[2-(3-Phenylpropylamino)-et'ny:L]-3-phenyl~
pyrazole .
~L~
- 13 E~OE 82/F _025 From 3-t;m:ino-2-belzoyl-1-(3-pheny]propyl)--4,5-dihydro-pyrro].e by tr~atment with hydra.~ine in i.sopropanol aeeordin~ to Examp]e 1e.
Example 1 0 5-[2-Benzy].amino_ethyll-3--~4-ehlorophenyl~~eyrazol_ a) N-Benzyl-N-(2-(4-chloropllenyl)-2-oxo-ethyl)-3-arnino-propionie aeid nitrile From 4-ehlorophenacylbromide and 3-(benzylamino)--propionie acid ni-trile according -to Exampl.e 1a.
b) 3-Amino-2-(4-chlorohenzoyl)-1~benzyl-4,5-dlhydro-pyrrole From N-(senzyl)-N~(2-(4-chlorophenyl)-2-os~o-~thyl)-3-amino-propionic aeid nitrile by treatment with methylate . aeeording to Example 1b.
e) 5-[2-Benzylamino-ethyl]-3-(4-ehlorophenyl)-pyrazole From 3-amino-2-(4-chlorobenzoyl)-1-benzyl 4,5-dihydro-pyrrole by treatment with hydrazine in ethanol aceording to Example 1c.
m.p.: 182-184C (HCl) Example 11_ 5-[2-(Chlorobenzylamino)-ethyl-3- 4-chlorophenyl) _ pyrazole a) N-(2-Chlorobenzyl)-N-[2-(4-ehlorophenyl)-2-oxo' ethyl]-3-amino-propionie acid ni-trile From 4-chlorophenacylbromide and 3-(2-chlorobenzylamino~-propionie acid nitri.le aceording to Example 1a.
b) 3--Amino 2-l4-ehlorohenzoyl)-1-(2-chloroberlzyl)-
4,5-dihydro-pyrl.ole.
From N-(2-chlorobenzyl)-N-[2-(4-ehlorophenyl)-2-oxo-ethyl]-3-amino-propionie acid ni.trile by trea.tment with methylate aceording to Example 1b.
e) 5-[2-(2-Chlorobenzylamino)-ethyl]-3-(4-ehloro~-phenyl)-pyrazole.
From 3-amino-2-(4-chlorohenzoyl)--1-(2--chlcjrobc-~nzyl) 4,5-dihydro-pyrrole by treatment with hydrazine i.n alcoho].
aecording to Exarr.ple 1c.
m.p.: 241 C (2 HCl) .
~36~
- 14 - ~IOE S2/F 02 E ~mple 12 S-[2-Me 1 ]am~no-e-tllyl]-3-(4 chl_rophen~lL-J~yxazo~e a) N-Methyl-N-[2-(4-chlorophenyl)-2-oxo-ethyl]-3-amino-propionic acid nitrile Erom 4-chlorophenacylbromide and 3--methylamino-propionic acid nitrile according to Example 1a.
b) 3-Amino-2-(4-chlor~be~oyl)-1-methy]--4,5-dihydro-pyrrole.
From N--methyl-N-[2-(~-chlorophenyl)-2-oxo-etilyl]-3-amino-propionic acid nitrile by treatment with methylate according to Example 1b.
m.p.: 143C.
c~ 5-[2-Methy]amino-etllyl]-3-(4-chloropllerlyl)-pyrazole From 3-amino-2-(4-chlorobenzoyl)-1-methyl-4,5-dihydr-o--pyrrole by treatment with hydrazine in alcohol according to Example 1c.
m.p. 118C.
Example 13
From N-(2-chlorobenzyl)-N-[2-(4-ehlorophenyl)-2-oxo-ethyl]-3-amino-propionie acid ni.trile by trea.tment with methylate aceording to Example 1b.
e) 5-[2-(2-Chlorobenzylamino)-ethyl]-3-(4-ehloro~-phenyl)-pyrazole.
From 3-amino-2-(4-chlorohenzoyl)--1-(2--chlcjrobc-~nzyl) 4,5-dihydro-pyrrole by treatment with hydrazine i.n alcoho].
aecording to Exarr.ple 1c.
m.p.: 241 C (2 HCl) .
~36~
- 14 - ~IOE S2/F 02 E ~mple 12 S-[2-Me 1 ]am~no-e-tllyl]-3-(4 chl_rophen~lL-J~yxazo~e a) N-Methyl-N-[2-(4-chlorophenyl)-2-oxo-ethyl]-3-amino-propionic acid nitrile Erom 4-chlorophenacylbromide and 3--methylamino-propionic acid nitrile according to Example 1a.
b) 3-Amino-2-(4-chlor~be~oyl)-1-methy]--4,5-dihydro-pyrrole.
From N--methyl-N-[2-(~-chlorophenyl)-2-oxo-etilyl]-3-amino-propionic acid nitrile by treatment with methylate according to Example 1b.
m.p.: 143C.
c~ 5-[2-Methy]amino-etllyl]-3-(4-chloropllerlyl)-pyrazole From 3-amino-2-(4-chlorobenzoyl)-1-methyl-4,5-dihydr-o--pyrrole by treatment with hydrazine in alcohol according to Example 1c.
m.p. 118C.
Example 13
- 5-[2-(4-Chlorobenzylamino)-e-thyl]-3-phen~ y~_ole a) N-(~-Chlorobenzyl)-N-[2-phenyl 2-oxo ethyl]-3-amino-propionic acid nitrile.
From phenacylbromide and 3-(4-cllloroberlzylamino)-propionic acid nitrile accordincJ to Example 1a~
b) 3-Amino-2-benzoyl-1--(4-ch]orobenzyl)--4,5-dihydro--pyrrole.
From N-(~--chlorobenzy])-N--[2-phenyl-2-oxo-ethyl]-3-amino-propionic acid nitrile by treatment with methylate - according to Example 1b.
m.p.: 175C
c) 5-[2-(4-Chlorobenzylamino)-etllyl]--3-phenyl-pyLazole From 3-amino-2-benzoyl-1-~(4~ch]orobenzyl)-~,S-dihydro-pyrrole by treatmellt with hydrazine ln alcohol according -to Example 1c.
m.p.: 156C (2 ~Cl~
3&it)~ ~
Example 19 _ _ 5-[2-(2-Ch_orobenz~amino)-eth~ phenyl-~yrazole _ a) N-(2-Cnlorobenæyl-N-[2-phenyl-2-oxo-ethyl]~3-amino-propionic acid nitrile.
From phenacylbromide and 3-(2-chlorobenzylamino)-propionic acicl nitrile according to Example1a.
b) 3-~nino--2-benzoyl-1 (2-chlorobenzyl)~4,5-dihyc1ro-pyrro]e.
From N-~2-chlorobenzyl)-N-[2-phenyl-2-oxo-ethyl]-3-amino-propionic acid nitrile by treatment w:ith methylate according to ~xample 1b.
m.p.: 151C
c) 5-[2-(2--Chlorobenzylamino)-ethy]]-3-phenyl-pyrazole From 3-amino-2-benzoyl-1-(2-chlorobenzy])-4,5-dihydro-pyrrole by treatment with hydrazine in alcohol according to Example 1c.
Example 15 5-(2-AminQethyl)-3-p}1eny]-pyrazole From 5-(2-benzylaminoethyl)--3-phenylpyrazole by catalytic hydrogenation with Raney nickel as catalyst in methanol at 50C and 50 atmospheres gage within 50 hours of reaction time. After separation of the catalyst, an oil is obtained which can be crystallized from ethyl acetate.
M.p. 118-120C
From phenacylbromide and 3-(4-cllloroberlzylamino)-propionic acid nitrile accordincJ to Example 1a~
b) 3-Amino-2-benzoyl-1--(4-ch]orobenzyl)--4,5-dihydro--pyrrole.
From N-(~--chlorobenzy])-N--[2-phenyl-2-oxo-ethyl]-3-amino-propionic acid nitrile by treatment with methylate - according to Example 1b.
m.p.: 175C
c) 5-[2-(4-Chlorobenzylamino)-etllyl]--3-phenyl-pyLazole From 3-amino-2-benzoyl-1-~(4~ch]orobenzyl)-~,S-dihydro-pyrrole by treatmellt with hydrazine ln alcohol according -to Example 1c.
m.p.: 156C (2 ~Cl~
3&it)~ ~
Example 19 _ _ 5-[2-(2-Ch_orobenz~amino)-eth~ phenyl-~yrazole _ a) N-(2-Cnlorobenæyl-N-[2-phenyl-2-oxo-ethyl]~3-amino-propionic acid nitrile.
From phenacylbromide and 3-(2-chlorobenzylamino)-propionic acicl nitrile according to Example1a.
b) 3-~nino--2-benzoyl-1 (2-chlorobenzyl)~4,5-dihyc1ro-pyrro]e.
From N-~2-chlorobenzyl)-N-[2-phenyl-2-oxo-ethyl]-3-amino-propionic acid nitrile by treatment w:ith methylate according to ~xample 1b.
m.p.: 151C
c) 5-[2-(2--Chlorobenzylamino)-ethy]]-3-phenyl-pyrazole From 3-amino-2-benzoyl-1-(2-chlorobenzy])-4,5-dihydro-pyrrole by treatment with hydrazine in alcohol according to Example 1c.
Example 15 5-(2-AminQethyl)-3-p}1eny]-pyrazole From 5-(2-benzylaminoethyl)--3-phenylpyrazole by catalytic hydrogenation with Raney nickel as catalyst in methanol at 50C and 50 atmospheres gage within 50 hours of reaction time. After separation of the catalyst, an oil is obtained which can be crystallized from ethyl acetate.
M.p. 118-120C
Claims (2)
OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for the preparation of a substituted phenyl-pyrazole derivative of the formula I
I
and the salts thereof with physiologically acceptable acids, wherein R1 and R2, which may be identical or different, are hydrogen, halogen, alkyl or alkoxy having from 1 to 4 carbon atoms, nitro or amino, R3 is hydrogen, a saturated or unsaturated, linear or branched alkyl radical having from 1 to 8 carbon atoms, or a cycloalkyl radical having from 5 to 8 carbon atoms; the alkyl or cyclo-alkyl radical in turn may be substituted by a phenyl radical or a phenyl radical which may be mono- or disubstituted by halogen, nitro, amino or alkyl or alkoxy having from 1 to 4 carbon atoms, in which an aminopyrroline of the formula II
II
wherein R1 to R3 are as defined above, is reacted with hydrazine or its hydrate to yield a compound of the formula I, a compound of the formula I wherein R3 is benzyl may be converted to a compound of the formula I in which R3 is hydrogen by splitting off the benzyl group, and a physiologically acceptable salt may be prepared by reaction with a physiologically acceptable acid.
I
and the salts thereof with physiologically acceptable acids, wherein R1 and R2, which may be identical or different, are hydrogen, halogen, alkyl or alkoxy having from 1 to 4 carbon atoms, nitro or amino, R3 is hydrogen, a saturated or unsaturated, linear or branched alkyl radical having from 1 to 8 carbon atoms, or a cycloalkyl radical having from 5 to 8 carbon atoms; the alkyl or cyclo-alkyl radical in turn may be substituted by a phenyl radical or a phenyl radical which may be mono- or disubstituted by halogen, nitro, amino or alkyl or alkoxy having from 1 to 4 carbon atoms, in which an aminopyrroline of the formula II
II
wherein R1 to R3 are as defined above, is reacted with hydrazine or its hydrate to yield a compound of the formula I, a compound of the formula I wherein R3 is benzyl may be converted to a compound of the formula I in which R3 is hydrogen by splitting off the benzyl group, and a physiologically acceptable salt may be prepared by reaction with a physiologically acceptable acid.
2. A substituted phenylpyrazole derivative of the formula I as defined in claim 1, and the salts thereof with physiologically acceptable acids, whenever obtained according to a process as claimed in claim 1 or by an obvious chemical equivalent thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP3205187.5 | 1982-02-13 | ||
DE19823205187 DE3205187A1 (en) | 1982-02-13 | 1982-02-13 | SUBSTITUTED PHENYLPYRAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS BASED ON THESE COMPOUNDS, AND THE USE THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1193606A true CA1193606A (en) | 1985-09-17 |
Family
ID=6155656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000421424A Expired CA1193606A (en) | 1982-02-13 | 1983-02-11 | Substituted phenylpyrazole derivatives, process for their preparation, medicaments based therein, and their use |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0086450B1 (en) |
JP (1) | JPS58148862A (en) |
AT (1) | ATE20057T1 (en) |
CA (1) | CA1193606A (en) |
DE (2) | DE3205187A1 (en) |
ES (1) | ES8401475A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4826868A (en) * | 1986-05-29 | 1989-05-02 | Ortho Pharmaceutical Corporation | 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use |
JP2519950Y2 (en) * | 1993-03-31 | 1996-12-11 | 住金鋼材工業株式会社 | Structure of connection between pillar and decoration beam |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3997555A (en) * | 1974-12-23 | 1976-12-14 | Sandoz, Inc. | 4-Phenyl-1-hydroxyalkylpyrazoles |
JPS5740466A (en) * | 1980-08-25 | 1982-03-06 | Kuraray Co Ltd | Aminoethyl-substituted pyrazole derivative and its preparation |
-
1982
- 1982-02-13 DE DE19823205187 patent/DE3205187A1/en not_active Withdrawn
-
1983
- 1983-02-09 AT AT83101224T patent/ATE20057T1/en not_active IP Right Cessation
- 1983-02-09 EP EP83101224A patent/EP0086450B1/en not_active Expired
- 1983-02-09 DE DE8383101224T patent/DE3363640D1/en not_active Expired
- 1983-02-10 JP JP58019893A patent/JPS58148862A/en active Pending
- 1983-02-11 CA CA000421424A patent/CA1193606A/en not_active Expired
- 1983-02-11 ES ES519727A patent/ES8401475A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0086450B1 (en) | 1986-05-28 |
EP0086450A2 (en) | 1983-08-24 |
ES519727A0 (en) | 1983-12-01 |
ATE20057T1 (en) | 1986-06-15 |
EP0086450A3 (en) | 1984-05-30 |
DE3205187A1 (en) | 1983-08-25 |
ES8401475A1 (en) | 1983-12-01 |
DE3363640D1 (en) | 1986-07-03 |
JPS58148862A (en) | 1983-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2677984A1 (en) | N-SUBSTITUTED IMIDAZOLINE DERIVATIVES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
FR2517303A1 (en) | IMIDAZOLE DERIVATIVES | |
FR2665898A1 (en) | AMIDO-3 PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
JPS59193875A (en) | Imidazolines, related compounds and their synthesis | |
US4663320A (en) | (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof | |
SK13012000A3 (en) | Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors | |
US4568687A (en) | N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions | |
CA1120471A (en) | Adamantylmethyl hydrazines, their preparation and pharmaceutical composition containing them | |
US4870095A (en) | 1H-pyrazole-1-alkanamides, antiarrhythmic compositions and use | |
CA1193606A (en) | Substituted phenylpyrazole derivatives, process for their preparation, medicaments based therein, and their use | |
BG98812A (en) | Therapeutical compounds | |
JPH04295470A (en) | 1,2,4-oxadiazole derivative having monoamine oxidase b enzyme inhibiting activity and its production | |
US4150154A (en) | Amidinoureas | |
US4208420A (en) | New benzo [d] thiazole derivatives, process for their preparation and their therapeutic applications | |
US3953467A (en) | Pyrazole derivatives and process for preparing the same | |
CH407088A (en) | Process for the preparation of 4-halo-3-sulfamoyl-benzoic acid derivatives | |
US4086361A (en) | Aminoethyl oximes having anti-depressive activity | |
JPH03501972A (en) | Dopamine-β-hydroxylase inhibitor | |
WO2012151958A1 (en) | Low-toxic 3-pyrazole carboxylic acid amides, preparation methods and uses thereof in manufacture of medicines as cb1 receptor inhibitors | |
US4530843A (en) | Isoindole amidoxime derivatives | |
US3995046A (en) | Esters of 5-n-butylpyridine-2 carboxylic acid and pharmaceutical compositions containing these compounds | |
US4069333A (en) | Anti-hypertensive compositions | |
DE69521295T2 (en) | TRIAZOLE DERIVATIVES | |
FR2655044A1 (en) | (HETERO) ARYLMETHYLOXY-4-PHENYL TETRAZOLE AND OXADIAZOLE DERIVATIVES, PROCESS FOR PREPARING THEM AND THEIR USE IN THERAPEUTICS. | |
US4216230A (en) | Method for alleviating hypertension with amidinoureas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEC | Expiry (correction) | ||
MKEX | Expiry |